IBIOIllinois Biotechnology Industry Organization
References in periodicals archive ?
Under the supply agreement, iBio will formulate and fill clinical research quantities of one of the customer's investigational therapies into sterile vials for use in a planned late-stage clinical trial.
The IBio facility offers about 205,000 gsf to support research themes, including biomedical engineering, cardiovascular, diabetes and metabolism, behavioral science and computational biology.
10 January 2012 -- US biotech iBio Inc (NYSEAMEX:IBIO) said on Monday it had assigned Roth Capital Partners the role of sole manager of its proposed offering of stock and warrants.
* Ibio Inc (NYSE:IBIO) rose 22.6% to $0.84 in pre-market trading after the company announced an expansion of its collaboration with CC-Pharming by granting it an exclusive, royalty-bearing commercial license to rituximab.
iBio announced the activation of its new cGMP sterile fill-finish services operation via the signing of a supply agreement with a clinical-stage biopharmaceutical company developing breakthrough gene and cell therapies.
In a study conducted by the iBIO, Illinois demonstrated the strongest revenue growth in the Midwest, with an average annual growth of 13.3%.
Biotechnology company iBio (NYSE MKT:IBIO) reported on Monday the receipt of the new Canadian plague patent under its iBioModulator thermostable immunomodulator protein portfolio.
[USPRwire, Fri Dec 12 2014] Global Markets Direct's, 'iBio, Inc.
Ltd., ImmunoVaccine Technologies Inc., Acetylon Pharmaceuticals, Inc., Etubics Corporation, iBio, Inc., PepTcell Limited, Genocea Biosciences, Inc., Hawaii Biotech, Inc., Georgia Tech Research Corporation, Sigma-Tau Pharmaceuticals, Inc., Selecta Biosciences, Inc., Artificial Cell Technologies, Inc., Pfenex Inc., NeED Pharma s.r.l., VLP Biotech, Inc., Jom Pharma GmbH
iBio is a biopharmaceutical company focused on developing products for the prevention and treatment of infectious diseases.